Industry and Scientific Applications
Early access partners have reported specific outcomes using the model. Alex Cabrera, Founding Engineer at Axiom Bio, stated, "On our Scientific Agent Benchmark, Gemini 4 was at the frontier across most tasks, including our hardest: ranking the clinical risk between two drugs." Gopal Srinivasan, Global AI and Data Lead at Deloitte, noted that in their evaluations, the model "completed successfully 100% of the time" for long-running tasks.
In the medical field, Brendan Fortuner, SVP Technology at Ambience Healthcare, reported that Gemini 4 "achieved the highest recall and ICD-10 code specificity among the models we evaluated" on complex synthetic longitudinal charts. In legal tech, Caio Perona, CEO of MinutaIA, said the model "actually surpassed our human expert's answer key by surfacing a legally relevant detail we had missed" in one evaluation.
Google also highlighted scientific breakthroughs, including the use of Argon to help discover a broader class of counterexamples to "Grad’s conjecture" in nuclear fusion research, alongside Professor Matt Landreman of the University of Maryland. In enzyme design, Google scientists reported that Argon identified five novel designs for serine esterases in a matter of hours, with subsequent laboratory testing confirming robust catalytic activity.